These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1975485)
1. Comparative effects of esmolol and verapamil in a model of a supraventricular tachydysrhythmia. Tuman KJ; McCarthy RJ; Wong CA; Labarge AM; Spiess BD; Ivankovich AD Anesthesiology; 1990 Sep; 73(3):467-73. PubMed ID: 1975485 [TBL] [Abstract][Full Text] [Related]
2. A new dosing regimen for esmolol to treat supraventricular tachyarrhythmia in Chinese patients. Ko WJ; Chu SH J Am Coll Cardiol; 1994 Feb; 23(2):302-6. PubMed ID: 7905013 [TBL] [Abstract][Full Text] [Related]
3. [The hemodynamic effects of a treatment with beta-receptor blockers during coronary surgery. A comparison between acebutolol and esmolol]. Kling D; Boldt J; Zickmann B; Dapper F; Hempelmann G Anaesthesist; 1990 May; 39(5):264-8. PubMed ID: 1972611 [TBL] [Abstract][Full Text] [Related]
4. Control of tachycardia and hypertension following coronary artery bypass graft surgery: efficacy and haemodynamic effects of esmolol. Tempe DK; Mulchandani P; Tandon MS; Mehta N; Tomar AS; Banerjee A; Khanna SK Indian Heart J; 1999; 51(3):294-300. PubMed ID: 10624069 [TBL] [Abstract][Full Text] [Related]
5. Esmolol and left ventricular function in the awake dog. Jacobs JR; Maier GW; Rankin JS; Reves JG Anesthesiology; 1988 Mar; 68(3):373-8. PubMed ID: 2894187 [TBL] [Abstract][Full Text] [Related]
6. Efficacy of esmolol in the treatment and transfer of patients with supraventricular tachyarrhythmias to alternate oral antiarrhythmic agents. Das G; Tschida V; Gray R; Dhurandhar R; Lester R; McGrew F; Askenazi J; Kaplan K; Emanuele M; Turlapaty P J Clin Pharmacol; 1988 Aug; 28(8):746-50. PubMed ID: 2905710 [TBL] [Abstract][Full Text] [Related]
10. Interactions of esmolol and adenosine in atrioventricular nodal-dependent supraventricular tachycardia: implication for the cellular mechanisms of adenosine. Chang KC; Lin YC; Chen JY; Chou HT; Hung JS Cardiology; 2002; 97(3):138-46. PubMed ID: 12077566 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular effects of verapamil enantiomer combinations in conscious dogs. Pagel PS; Hettrick DA; Lowe D; Gowrie PW; Kersten JR; Bosnjak ZJ; Warltier DC Eur J Pharmacol; 1998 May; 348(2-3):213-21. PubMed ID: 9652336 [TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and antiarrhythmic effects of esmolol in children. Trippel DL; Wiest DB; Gillette PC J Pediatr; 1991 Jul; 119(1 Pt 1):142-7. PubMed ID: 1676729 [TBL] [Abstract][Full Text] [Related]
13. Esmolol versus verapamil in the acute treatment of atrial fibrillation or atrial flutter. Platia EV; Michelson EL; Porterfield JK; Das G Am J Cardiol; 1989 Apr; 63(13):925-9. PubMed ID: 2564725 [TBL] [Abstract][Full Text] [Related]
14. Esmolol: a titratable short-acting intravenous beta blocker for acute critical care settings. Turlapaty P; Laddu A; Murthy VS; Singh B; Lee R Am Heart J; 1987 Oct; 114(4 Pt 1):866-85. PubMed ID: 2889341 [TBL] [Abstract][Full Text] [Related]
15. The class III antiarrhythmic effect of sotalol exerts a reverse use-dependent positive inotropic effect in the intact canine heart. Peralta AO; John RM; Gaasch WH; Taggart PI; Martin DT; Venditti FJ J Am Coll Cardiol; 2000 Oct; 36(4):1404-10. PubMed ID: 11028502 [TBL] [Abstract][Full Text] [Related]